Researchers have developed a noninvasive diagnostic technique using DNA methylation biomarkers from bilateral nasal swabs to detect nasopharyngeal carcinoma early. Published in BMC Cancer, this epigenetic approach presents a significant advance in cancer screening with potential for widespread clinical application.